Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ: IRWD · Real-Time Price · USD

3.370

-0.010 (-0.30%)

At close: Mar 13, 2026, 4:00 PM EDT

3.470

+0.100 (2.97%)

After-hours: Mar 13, 2026, 7:51 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Human Therapeutics	296.15M	351.41M	442.74M	410.60M	413.75M
Human Therapeutics Growth	-15.72%	-20.63%	7.83%	-0.76%	6.22%
Total	296.15M	351.41M	442.74M	410.60M	413.75M
Total Growth	-15.72%	-20.63%	7.83%	-0.76%	6.22%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	289.34M	341.22M	432.99M	402.79M	404.65M
United States Growth	-15.20%	-21.20%	7.50%	-0.46%	8.44%
Rest of World	6.81M	10.19M	9.74M	7.80M	9.10M
Rest of World Growth	-33.16%	4.63%	24.85%	-14.30%	-44.36%
Total	296.15M	351.41M	442.74M	410.60M	413.75M
Total Growth	-15.72%	-20.63%	7.83%	-0.76%	6.22%

Source: S&P Global Market Intelligence.